#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic lupus erythematosus Synovial sarcoma recurrent Hypomagnesaemia Splenic marginal zone lymphoma Retinal dystrophy Cold type haemolytic anaemia Small intestine adenocarcinoma Thrombotic thrombocytopenic purpura Rhabdomyosarcoma Osteosarcoma metastatic Immune-mediated renal disorder Mixed-type liposarcoma Malignant melanoma Ovarian cancer Hairy cell leukaemia More trials…

    Learn about Rare Diseases

    Myxofibrosarcoma – Diagnostics Angiosarcoma recurrent – Treatment Medulloblastoma recurrent – Treatment Focal segmental glomerulosclerosis – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Mantle cell lymphoma – Trials in Disease Undifferentiated sarcoma – Basic Information Hereditary angioedema – Treatment Synovial sarcoma recurrent – Trials in Disease Ewing’s sarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rilzabrutinib Budesonide Water For Injection Melatonin Favezelimab Gsk4004280 Cilgavimab Lbl-007 GXV813 Specific Nucleic Acid Sna-Veru Rilpivirine Hydrochloride Icosapent Ethyl Gallium (68Ga) LTG-001 Potassium Chloride Pemetrexed Diacid Monohydrate IADADEMSTAT Esomeprazole Avalglucosidase Alfa Vatiquinone More therapies…

    Learn about Your Condition

    Incisional hernia Myxoid liposarcoma Psychological trauma Congenital myopathy Angiosarcoma Type IIa hyperlipidaemia Abdominal wall pain Erdheim-Chester disease Polycystic liver disease Overweight Mucopolysaccharidosis III Ovarian epithelial cancer Univentricular heart Substance use disorder Back pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatoid arthritis

  • Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Methotrexate
    Austria Italy The Netherlands Norway Romania Sweden

  • Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Baricitinib
    • Etanercept
    • Adalimumab
    France

  • Study on Reducing JAK Inhibitor Doses in Patients with Low Disease Activity in Rheumatoid Arthritis Using Tofacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Baricitinib
    • Tofacitinib
    France

  • Study on Sarilumab and Etanercept for Rheumatoid Arthritis in Patients Not Responding to csDMARD Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sarilumab
    • Etanercept
    Belgium Germany Italy The Netherlands Portugal Spain

  • Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rituximab
    Belgium

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France
Previous Page
1 2 3 4 5 6 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!